Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Pediatric Hepatobiliary Diseases and Treatments, Gallbladder and Bile Duct Disorders, Liver Diseases and Immunity, and Drug Transport and Resistance Mechanisms.
Anonymous living donation expands access and enhances equity in pediatric liver transplantation: A retrospective cohort study.
IBAT inhibitors in pediatric cholestatic liver diseases: Transformation on the horizon?
Children with autoimmune hepatitis receiving standard-of-care therapy demonstrate long-term obesity and linear growth delay.
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (<scp>PSC‐IBD</scp>): A matched analysis from the Paediatric <scp>PSC</scp> Consortium
Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.
Interleukin 8-CXCR2–mediated neutrophil extracellular trap formation in biliary atresia associated with neutrophil extracellular trap–induced stellate cell activation
Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA
Notch signaling in thyrocytes is essential for adult thyroid function and mammalian homeostasis
Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor.
A pilot feasibility study of an ultrasound-based tool to assess muscle mass in children with liver disease
Severe acute hepatitis of unknown etiology in a large cohort of children.
Loss of zebrafish <i>pkd1l1</i> causes biliary defects that have implications for biliary atresia splenic malformation
Early diagnosis of ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis syndrome: A case report
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial
Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study
Cholestatic liver diseases of genetic etiology: Advances and controversies
Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease
Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency
Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency
Use of a Comprehensive 66‐Gene Cholestasis Sequencing Panel in 2171 Cholestatic Infants, Children, and Young Adults
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study
Genotype correlates with the natural history of severe bile salt export pump deficiency
Outcomes of Childhood Cholestasis in Alagille Syndrome: Results of a Multicenter Observational Study
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children
Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age
Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease